Not to be inj IV or IM. Hypo- or hyperglycaemia, diabetic ketoacidosis; adrenal, pituitary or thyroid gland diseases; concomitant illness or emotional disturbances. Physical activity or diet changes. Formation of insulin Ab. Risk of developing lipodystrophy & cutaneous amyloidosis; monitor blood glucose after change of inj site. Transferring to another insulin type or brand. Not to be mixed w/ other insulin prep. Combination w/ thiazolidinediones. May affect ability to drive & use machines. Renal or hepatic impairment. Pregnancy & lactation.
Sign Out
